Effectiveness of Motivational Interviewing in Patients With COPD

NCT06783582 | Recruiting

• 1 other identifier: Thesis
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

To determine the effect of motivational interviewing based on Pender's health promotion model on patient-reported outcomes in patients with COPD.

Conditions

COPD; Nurse-Patient Relations

Keywords

Patient-reported Outcomes; Nurse; COPD; Motivational Interviewing; Pender's Health Promotion Model

Outcome Measures

Primary Outcomes (3)

• Adapted Patient Reported Outcome Scale for Chronic Obstructive Pulmonary Disease

  The Turkish validity and reliability study of the scale developed by Liu et al. in 2020 was conducted by Sazak and Orgun in 2023. The scale consists of 27 items in three dimensions. The dimensions are physical domain, environmental domain and psychological domain. The scale is a 5-point Likert type (Never 0, Almost never 1, A few times 2, Many times 3, Almost always 4). Item 13 should be reverse scored. Cronbach's Alpha reliability coefficient of the scale was determined as 0.954 for the overall scale, 0.945 for the physical domain sub-dimension, 0.862 for the psychological domain sub-dimension and 0.828 for the environmental sub-dimension.

  Up to 4 weeks

• Modified Medical Research Council (mMRC) Dyspnea Scale

  The dyspnea scale, developed by Fletcher in 1952, was used to compare the dyspnea levels of individuals with lung disease and those without during activity. Later, the scale was developed by the British Medical Research Council (MRC) to evaluate the course of diseases. The scale, which is based on various physical activities to determine dyspnea, consists of 5 items and is scored between 0 and 4 points. The best point in terms of dyspnea on the scale is 0, while the worst is defined as 4 points.

  Up to 4 weeks

• COPD Assessment Test (CAT)

  Developed by Jones et al. in 2009, the scale was validated in Turkish by Yorgancıoğlu et al. in 2012. CAT determines disease severity by evaluating symptoms such as cough, phlegm, shortness of breath, fatigue, and leaving home. The scores of the questions in the test range from "0-40". CAT assessment test score; 0-10 is considered "low impact", 11-20 is considered "moderate impact", 21-30 is considered "high impact", and 31-40 is considered "very high impact".

  Up to 4 weeks

Study Arms (2)

Motivational Interviewing

EXPERIMENTAL

The intervention group will given 30-45 minutes of motivational interviewing.

Other: Motivational interviewing based on Pender's health promotion model

Control Group

NO INTERVENTION

Routine nursing care was given to COPD patients in this group without any interview.

Interventions

Motivational interviewing based on Pender's health promotion model OTHER

In addition to routine nursing care, patients will be given a motivational interview intervention based on Pender's health promotion model. This intervention will be carried out in a total of 6 sessions, three face-to-face sessions and three online sessions planned individually for each patient. The interviews will last approximately 30-45 minutes. The first motivational interview will be held on the 1st day of the patient's admission to the clinic, the second motivational interview on the 4th day, and the third motivational interview on the 7th day. The face-to-face sessions will be conducted by the researcher in the hospital's education room and contact information will be obtained from the patients. The following three interviews will be held online with the patients once a week via the WhatsApp application. The patient will be contacted at least two days before the interviews, an appointment will be made, and the interview day and time will be determined.

Motivational Interviewing

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being over 18 years of age,
• Volunteering to participate in the study,
• Being literate,
• Having GOLD Stage II and III COPD,
• Receiving COPD treatment for more than 6 months,
• Having a smartphone for online interviews,
• Not having sensory loss related to hearing and vision,
• Not having a history of psychiatric diagnosis,
• Being suitable for applying cognitive level scales.

You may not qualify if:

• Having GOLD Stage I and IV COPD,
• Having serious pulmonary and malignant disease,
• Not being able to communicate in Turkish,
• Being in an exacerbation period,
• Having a history of psychiatric diagnosis.

Sponsors & Collaborators

• Zeynep Yildirim: lead

Study Sites (1)

Ataturk University

Erzurum, 25700, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: January 15, 2025
• First Posted: January 20, 2025
• Study Start: March 29, 2024
• Primary Completion: February 24, 2025
• Study Completion: March 30, 2025
• Last Updated: January 22, 2025

Record last verified: 2025-01

Locations

TU (1)